18348-Human Phototoxicity Test
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Registration Number
- NCT02823483
- Lead Sponsor
- Bayer
- Brief Summary
To determine the phototoxic potential of a topically applied article in human subjects
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- be male or female between the ages of 18 and 60 inclusive;
- be lightly pigmented (Fitzpatrick Skin Type I, II, III);
- have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form in conformance with 45CFR Parts 160 and 164;
- be in general good health as determined by the subject's medical history and in the discretion of the investigator;
Exclusion Criteria
- have a visible sunburn;
- have a history of sun hypersensitivity/photosensitivity or photosensitive dermatosis;
- must not have a known sensitivity or allergy against any of the active and non-active ingredients of the test product.
- have a history of allergies or sensitivities to cosmetics, toiletries or any dermatological products
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Intensity of skin reactions will be evaluated using the 5 point Up to 48 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the phototoxic potential of BAY987521 sunscreen lotion in human subjects?
How does BAY987521 compare to standard-of-care sunscreen agents in preventing phototoxic reactions and UV-induced skin damage?
Are there specific biomarkers that correlate with phototoxic response to BAY987521 in clinical trials?
What are the potential adverse events associated with BAY987521 application and how are they managed in phototoxicity studies?
What related compounds or combination therapies has Bayer developed for phototoxicity prevention in sunscreen formulations?